HEYLTEX CORPORATION: $16.2M Department of Health and Human Services Contract
Summary
This $16.2M contract to private entity Heyltex Corporation for Prussian Blue (Radiogardase) capsules supports the Strategic National Stockpile's radiation countermeasure preparedness. No publicly traded companies are directly involved, limiting immediate stock market impact.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.Contract is to a private entity; no public tickers directly benefit.
- 2.Reinforces U.S. government commitment to radiation countermeasure stockpiling.
- 3.No related legislation in the provided bill signals directly connects to this award.
Market Implications
This contract has negligible direct market implications due to the private nature of the recipient. The biodefense sector may see thematic interest, but no specific tickers are actionable. Investors should look for future contract awards to public companies in the medical countermeasure space, such as those developing anthrax vaccines or nerve agent antidotes.
⚡ Government Convergence
This signal is one of the converging government actions below.
Over the last 90 days, 39 separate government actions have converged on Biodefense / Pandemic Preparedness. What that means: federal dollars are already moving — agencies are soliciting bids and awarding contracts, not just talking, and legislation and executive action are building the policy and funding tailwind behind it. When independent channels move together like this — 30 federal contracts, 8 procurement notices and 1 bills — it's the clearest early tell that Washington is committing to biodefense / pandemic preparedness, the kind of build-up that reshapes the sector well before it's obvious in the headlines.
Converging government actions
- BillBeagle Brigade Act of 2023 · 2024-12-23
- BillNo Flight, No Fight Act of 2026 · 2026-02-05
- ContractGLOBAL HEALTH INVESTMENT CORPORATION: OTHER TRANSACTION AGREEMENT: BARDA VENTURES · 2026-04-30
- Procurement noticeSources Sought Notice - Pandemic Preparedness Plan Evaluation · 2026-05-13
- Procurement noticeRFI - Medical Countermeasures for the Treatment of Drug-Resistant Fungal Infections · 2026-05-21
- Procurement noticeRPP: BEACON Program - Medical Countermeasure (MCM) Candidate Integration and Subcontractor Management · 2026-06-02
- Procurement noticeRequest for Project Proposal (RPP): BEACON Program - Medical Countermeasure (MCM) Candidate Integration and Subcontractor Management · 2026-06-03
- Procurement noticeRequest for Project Proposal (RPP): BEACON Program - Medical Countermeasure (MCM) Candidate Integration and Subcontractor Management · 2026-06-11
- ContractEMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.: ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM) · 2026-06-26
- ContractEMERGENT BIODEFENSE OPERATIONS LANSING LLC: CHIMERIX INC: AR&D FOR SMALLPOX ANTIVIRAL · 2026-07-08
- Procurement noticePresolicitation Notice - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response · 2026-07-30
- ContractHEYLTEX CORPORATION: $16.2M Department of Health and Human Services Contract · 2026-08-21
- ContractSHIONOGI INC: LATE-STAGE DEVELOPMENT, FDA MARKETING AUTHORIZATION, PROCUREMENT, AND STOCKPILE OF ANTIBIOTICS FOR THE TREATMENT OF DRUG-RESISTANT SECONDARY · 2026-08-21
- ContractSIGA TECHNOLOGIES, INC.: PROCUREMENT AND LATE-STAGE DEVELOPMENT OF SMALLPOX ANTIVIRAL DRUG(S) IGF::OT::IGF · 2026-08-24
Full Analysis
The Department of Health and Human Services, through the Office of Assistant Secretary for Preparedness and Response, awarded a $16.2M delivery order to Heyltex Corporation for Prussian Blue (Radiogardase) insoluble capsules (500mg). This drug is used to treat internal contamination with radioactive cesium or thallium. Heyltex is a privately held company, so no public equity is directly tied to this award. The contract period runs from September 2025 to September 2027, indicating a multi-year supply arrangement for the Strategic National Stockpile. While the award is modest in absolute terms, it underscores ongoing federal investment in medical countermeasures for radiological/nuclear threats. No related legislation in the provided bill signals directly authorizes or appropriates funds for this specific procurement; the contract likely falls under existing BARDA or ASPR authorities. Without a publicly traded parent company or known subcontractors, the contract's market impact is confined to the broader biodefense sector theme rather than any specific stock catalyst. Investors should note that similar stockpile contracts for niche pharmaceuticals often benefit specialty drug manufacturers, but Heyltex's private status prevents direct attribution.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
WG CRITICAL CARE, LLC: $10.6M Department of Health and Human Services Contract
GENENTECH USA, INC: $37.5M Department of Health and Human Services Contract
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Delivering Gold Standard Childhood Vaccine Recommendations for Americans
This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.
Continuing to Protect the Meaning and Value of American Citizenship
This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.
Ending Birth Tourism
This executive order directs the Secretaries of State and Homeland Security to prevent foreign nationals from entering the U.S. on nonimmigrant visas for the purpose of giving birth (birth tourism), including revoking visas, barring entry, and taking action against facilitators. It defines birth tourism as entry via nonimmigrant visa for childbirth and allows humanitarian or national interest exemptions.
Contract Details
Recipient
HEYLTEX CORPORATION
Award Amount
$16,199,859
Awarding Agency
Department of Health and Human Services
Sub-Agency
Office of Assistant Secretary for Preparedness and Response
Contract Type
DELIVERY ORDER
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →